The future of keto and GLP-1 research The clinical research pipeline for this specific combination is growing
Focus on whole foods rich in protein, healthy fats, and complex carbohydrates to sustain energy throughout the day
Nrf2-related signaling pathways play a key role in inflammation and cancer development in many organs, including the gut
Personalized Care from a Skilled Provider Rosaly Stephens, MSN, ARNP-C, brings years of aesthetic experience to Aspire MedSpa & Beauty Bar
A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered
These genetic markers do not predict exact medication response or guarantee side effect severity, but they may inform a more nuanced provider conversation about your individual tolerability risk and whether tirzepatide is the best choice among compounded GLP-1 or dual-peptide options
